Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemours (CC) Equity Income (2016 - 2025)

Historic Equity Income for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $9.0 million.

  • Chemours' Equity Income fell 1818.18% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year decrease of 1666.67%. This contributed to the annual value of $43.0 million for FY2024, which is 444.44% down from last year.
  • Per Chemours' latest filing, its Equity Income stood at $9.0 million for Q3 2025, which was down 1818.18% from $9.0 million recorded in Q2 2025.
  • Chemours' 5-year Equity Income high stood at $16.0 million for Q2 2022, and its period low was $7.0 million during Q4 2023.
  • Over the past 5 years, Chemours' median Equity Income value was $11.0 million (recorded in 2021), while the average stood at $11.2 million.
  • Its Equity Income has fluctuated over the past 5 years, first soared by 20000.0% in 2021, then plummeted by 3846.15% in 2025.
  • Over the past 5 years, Chemours' Equity Income (Quarter) stood at $11.0 million in 2021, then changed by 0.0% to $11.0 million in 2022, then plummeted by 36.36% to $7.0 million in 2023, then increased by 28.57% to $9.0 million in 2024, then changed by 0.0% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q3 2025, $9.0 million for Q2 2025, and $8.0 million during Q1 2025.